Harnessing collective expertise across Africa, the US, and Europe to investigate the etiology, improve early detection, and enhance the survival of patients with liver, biliary tract, and pancreatic cancers.
Hepatopancreatobiliary (HPB) cancers are rapidly fatal malignancies. In Africa, patients face unique challenges: significantly earlier onset ages, highly prevalent viral co-infections (HBV/HCV), and a lack of population-specific genomic data. We exist to change this paradigm.
Median diagnosis age in Africa is drastically lower (e.g., 46 years for HCC in many regions) compared to Western demographics.
High prevalence of chronic Hepatitis B/C and specific environmental factors require dedicated, localized pathobiological research.
Establishing robust clinical and population-based registries is critical for accurate risk assessment and early detection protocols.
Our Mission
Organized in 2020, AHPBCC unites oncologists, gastroenterologists, surgeons, pathologists, and cancer biologists. Together, we inform new strategies for risk prevention, early detection, and improved survival rates.
We develop and support dynamic collaborations between clinicians and researchers across Africa, the United States, and Europe.
Promoting high-quality, population-based basic and translational science focused on the pathobiology of African tumors.
Supporting the development of early-career researchers and clinicians through sponsored training and global mentorship networks.
Our recent collaborative assessment maps the capabilities of AHPBCC member institutions across Africa, identifying critical gaps in multidisciplinary team (MDT) management and the urgent need for expanded clinical registries for Liver and Pancreatic Cancers.
Read the Publication on ResearchGateBuilding on the success of our 2025 conference in Johannesburg, the 2026 meeting will convene global leaders to address the growing burden of hepatopancreatobiliary cancers. The program advances research on key risk factors, strengthens cross-continental collaboration, and emphasizes practical strategies to reduce mortality.
Collaborative Symposia & Partnerships
We invite oncologists, researchers, clinicians, and global health advocates to join our consortium. Together, we can share data, form multidisciplinary teams, and establish the registries necessary to change the trajectory of HPB cancers in Africa.